Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Equipment & Supplies
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:PMTI
- CUSIP: 69752930
- Web: N/A
- Trailing P/E Ratio:
- Foreward P/E Ratio: 46.24
- P/E Growth:
Frequently Asked Questions for Palomar Medical Technologies (NASDAQ:PMTI)
What is Palomar Medical Technologies' stock symbol?
Palomar Medical Technologies trades on the NASDAQ under the ticker symbol "PMTI."
Who are some of Palomar Medical Technologies' key competitors?
Some companies that are related to Palomar Medical Technologies include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Merck KGaA (MKGAY), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT), Cotiviti Holdings (COTV), Puma Biotechnology (PBYI), Hikma Pharmaceuticals Plc (HIK) and WuXi PharmaTech (Cayman) (WX).
How do I buy Palomar Medical Technologies stock?
Shares of Palomar Medical Technologies can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Palomar Medical Technologies' stock price today?
MarketBeat Community Rating for Palomar Medical Technologies (NASDAQ PMTI)MarketBeat's community ratings are surveys of what our community members think about Palomar Medical Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Palomar Medical Technologies stock can currently be purchased for approximately $13.41.
Consensus Ratings for Palomar Medical Technologies (NASDAQ:PMTI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Palomar Medical Technologies (NASDAQ:PMTI)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Palomar Medical Technologies (NASDAQ:PMTI)Earnings History by Quarter for Palomar Medical Technologies (NASDAQ PMTI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2013||Q1 2013||($0.01)||($0.06)||$20.30 million||$23.20 million||View||N/A|
|2/7/2013||Q4 2012||$0.04||$0.12||$22.70 million||$23.40 million||View||N/A|
Earnings Estimates for Palomar Medical Technologies (NASDAQ:PMTI)
Current Year EPS Consensus Estimate: $0.14 EPS
Next Year EPS Consensus Estimate: $0.29 EPS
Dividend History for Palomar Medical Technologies (NASDAQ:PMTI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Palomar Medical Technologies (NASDAQ:PMTI)Insider Trades by Quarter for Palomar Medical Technologies (NASDAQ:PMTI)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/12/2013||A Neil Pappalardo||Director||Sell||15,000||$13.45||$201,750.00|| |
|6/11/2013||Joseph P Caruso||CEO||Sell||21,711||$13.42||$291,361.62|| |
|6/7/2013||Joseph P Caruso||CEO||Sell||2,056||$13.47||$27,694.32|| |
|5/28/2013||Joseph P Caruso||CEO||Sell||40,000||$13.60||$544,000.00|| |
|5/24/2013||Joseph P Caruso||CEO||Sell||19,028||$13.58||$258,400.24|| |
|5/24/2013||Paul S Weiner||CFO||Sell||78,338||$13.59||$1,064,613.42|| |
|5/22/2013||Joseph P Caruso||CEO||Sell||20,000||$13.58||$271,600.00|| |
|5/17/2013||Joseph P Caruso||CEO||Sell||22,900||$13.58||$310,982.00|| |
|5/15/2013||Joseph P Caruso||CEO||Sell||70,000||$13.58||$950,600.00|| |
|5/14/2013||Paul S Weiner||CFO||Sell||40,485||$13.60||$550,596.00|| |
|5/9/2013||James G Martin||Director||Sell||14,756||$13.52||$199,501.12|| |
|11/15/2012||Broadwood Partners Lp||Major Shareholder||Buy||13,118||$7.19||$94,318.42|| |
Headline Trends for Palomar Medical Technologies (NASDAQ:PMTI)
Latest Headlines for Palomar Medical Technologies (NASDAQ:PMTI)
No headlines for this company have been tracked by MarketBeat.com
Palomar Medical Technologies (PMTI) Chart for Friday, July, 21, 2017